North America to account for larger share in atrial fibrillation market during 2022–2028; growth driven by rising geriatric population, increasing occurrence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and increasing healthcare expenditure
Feature | Atrial Fibrillation
Atrial Fibrillation Market Reaches $20.92B, According to New Report

According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by ...

Home April 04, 2023
Home
The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.
News | Hypertension
Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

Home April 04, 2023
Home
Results demonstrate significant reductions in LDL-C, hsCRP and cardiovascular risk in patients who are unable to maximize or tolerate a statin
News | Pharmaceuticals
Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population

April 3, 2023 — Esperion announced the full results from the landmark Cholesterol Lowering via Bempedoic acid, an ACL ...

Home April 03, 2023
Home
Clearance of the IND will pave the way for the Company to initiate its randomized controlled Phase 1/2a MOJAVE study in the US, planned for Q2 2023
News | Pharmaceuticals
Sequana Medical Announces Submission of Investigational New Drug (IND) Application for DSR 2.0 for Treatment of Congestive Heart Failure

April 3, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home April 03, 2023
Home
Here's a look at what viewers found most interesting during the month of March
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers were reading in March

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers ...

Home April 03, 2023
Home
According to a new release issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown
News | Intra-Aortic Balloon Pumps (IABP)
Datascope/Getinge Issues New Recall of Certain Cardiosave Hybrid and Rescue IABPs for Risk of Unexpected Shutdown

March 31, 2023 — According to statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home March 31, 2023
Home
The new valve is designed to preserve and facilitate future patient options for lifetime management of their heart valve disease
News | Structural Heart
Abbott Receives FDA Approval for Epic Max Tissue Valve to Treat Aortic Valve Disease

March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Epic Max ...

Home March 31, 2023
Home
They have discovered the cellular mechanism underlying this cardiovascular anomaly that is very common among people
News | Pediatric Cardiology
Scientists of the University of Malaga Found the Origin of Congenital Coronary Fistulae

March 31, 2023 — Scientists of the Department of Animal Biology of the University of Malaga have discovered the cellular ...

Home March 31, 2023
Home
New data shows steep increase of usually fatal heart condition during pandemic, with 38% increase for all county residents and 77% increase for Hispanic residents
News | Sudden Cardiac Arrest
Risk of Sudden Cardiac Arrest Rises Sharply in Ventura County

March 31, 2023 — In a study among residents of Ventura County, Calif., rates of sudden cardiac arrest rose sharply ...

Home March 31, 2023
Home
Vektor Medical has announced that use of its vMap arrhythmia mapping system during complex atrial fibrillation (AF) ablation was associated with significantly improved freedom from atrial arrhythmias compared with standard-of-care pulmonary vein isolation.
News | Atrial Fibrillation
New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study

March 30, 2023 —Vektor Medical has announced that use of its vMap arrhythmia mapping system during complex atrial ...

Home March 30, 2023
Home
Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders.
News | Robotic Systems
Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

March 30, 2023 — Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac ...

Home March 30, 2023
Home
The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future
News | Cardiovascular Education
Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology'

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

Home March 30, 2023
Home
The breakthrough findings solve a known problem for scientists working on cellular reprogramming, one of the most promising areas of regenerative medicine
News | Heart Failure
Heart Attack Study Could Change the Game in Regenerative Medicine

March 30, 2023 — Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to ...

Home March 30, 2023
Home
Growth-focused leader will help bring the company’s AI-powered cardiovascular technology to market 
News | Cardiovascular Business
Andrew Miller Joins Elucid as Chief Technology Officer

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men
News | Womens Cardiovascular Health
Women are More Likely to Experience Long-term Anxiety After Cardiac Arrest than Men

March 29, 2023 — More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men ...

Home March 29, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now